News Releases

Month Year

Month Year

Sep 24, 2014

Insmed to Participate in Leerink Partners' Rare Disease Roundtable
Sep 3, 2014

Insmed Announces Multiple Clinical and Scientific Presentations at European Respiratory Society's International Congress 2014
Aug 18, 2014

Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares
Aug 12, 2014

Insmed Announces Pricing of Public Offering of Common Stock
Aug 6, 2014

Insmed Reports Second Quarter 2014 Financial Results
Aug 4, 2014

Insmed Provides Regulatory Update for ARIKAYCE

Filing Marketing Authorization Application with European Medicines Agency for NTM Lung Disease and CF Indications
Jun 20, 2014

Insmed to Present at the JMP Securities Healthcare Conference
May 29, 2014

Insmed Appoints David R. Brennan to Its Board of Directors
May 20, 2014

Insmed Announces Positive Open Label Data from Phase 2 Clinical Trial of ARIKAYCE for Treatment Resistant Nontuberculous Mycobacterial Lung Infections

Poster Presentation at the American Thoracic Society Annual Meeting 2014
May 13, 2014

Insmed Announces Data Presentations for ARIKAYCE in Two Orphan Lung Diseases at the American Thoracic Society Meeting

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

View the latest Insmed Investor Presentation